HKSE:06915 (China)
Â
Class H
HK$
16.83
+0.33 (+2%)
Sep 10
Business Description
Jiangxi Institute of Biological Products Inc
ISIN : CNE100007Q61
Share Class Description:
HKSE:06915: Class HCompare
Compare
Traded in other countries / regions
06915.Hong Kong IPO Date
2026-06-30Description
Jiangxi Institute of Biological Products Inc is principally engaged in the business of research and development, and production and sale of human tetanus antitoxin. It operates as the provider and exporter of Human TAT in China and an antiserum platform company. Its products include biological products containing immunoglobulins or immunoglobulin F(ab')2 fragments, which are used in medical applications such as tetanus, snakebite envenoming, and rabies treatment. The majority of the company's revenue is derived from the sale of Human Tetanus Antitoxin in the Chinese mainland.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 82.8 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 3120.18 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 46.2 | |||||
Beneish M-Score | -1.66 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate Estimate | 48.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.2 | |||||
Quick Ratio | 3.14 | |||||
Cash Ratio | 1.21 | |||||
Days Inventory | 398.77 | |||||
Days Sales Outstanding | 114.89 | |||||
Days Payable | 63.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.75 | |||||
Operating Margin % | 45.59 | |||||
Net Margin % | 40.27 | |||||
EBITDA Margin % | 52.08 | |||||
FCF Margin % | 8.83 | |||||
OCF Margin % | 24.14 | |||||
ROE % | 21.36 | |||||
ROA % | 18.38 | |||||
ROIC % | 24.31 | |||||
ROC (Joel Greenblatt) % | 33.17 | |||||
ROCE % | 24.57 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 49.5 | |||||
PE Ratio without NRI | 42.93 | |||||
PS Ratio | 19.93 | |||||
PB Ratio | 9.46 | |||||
Price-to-Tangible-Book | 9.46 | |||||
Price-to-Free-Cash-Flow | 227.41 | |||||
Price-to-Operating-Cash-Flow | 82.49 | |||||
EV-to-EBIT | 41.3 | |||||
EV-to-EBITDA | 36.82 | |||||
EV-to-Revenue | 19.17 | |||||
EV-to-FCF | 217.12 | |||||
Price-to-Graham-Number | 4.24 | |||||
| Price-to-Net-Current-Asset-Value | 24.04 | |||||
| Price-to-Net-Cash | 420.75 | |||||
Earnings Yield (Greenblatt) % | 2.42 | |||||
FCF Yield % | 0.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangxi Institute of Biological Products Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 260.061 | ||
| EPS (TTM) (HK$) | 0.34 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 52.72 | ||
| 14-Day ATR (HK$) | 2.050671 | ||
| 20-Day SMA (HK$) | 16.68 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 3.95 - 21.1 | ||
| Shares Outstanding (Mil) | 308.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangxi Institute of Biological Products Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangxi Institute of Biological Products Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangxi Institute of Biological Products Inc Frequently Asked Questions
What is Jiangxi Institute of Biological Products Inc(HKSE:06915)'s stock price today?
The current price of HKSE:06915 is HK$16.83. The 52 week high of HKSE:06915 is HK$21.10 and 52 week low is HK$3.95.
When is next earnings date of Jiangxi Institute of Biological Products Inc(HKSE:06915)?
The next earnings date of Jiangxi Institute of Biological Products Inc(HKSE:06915) is .
Does Jiangxi Institute of Biological Products Inc(HKSE:06915) pay dividends? If so, how much?
Jiangxi Institute of Biological Products Inc(HKSE:06915) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jiangxi Institute of Biological Products Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers